CNS insiders

21 insiders have filed at CNS since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Steers Robert HamiltonExecutive Chairman11.99M23.234%20 buys $11.2M
Cohen MartinDirector9.02M17.484%4 buys $6.0M
Harvey Joseph MChief Executive Officer1.64M3.183%
Derechin Adam MChief Operating Officer, EVP536.1k1.039%
Cheigh JonPresident And CIO170.6k0.331%4 sells $3.6M
Stadler Matthew S.Chief Financial Officer, EVP147.8k0.287%
Charles Daniel PExecutive Vice President56.7k0.11%2 sells $712k
Poli Francis CGc, Secretary, EVP55.9k0.108%5 sells $2.7M
Villani Edmond DDirector40.3k0.078%3 sells $842k
Noonan DanielExecutive Vice President36.2k0.07%
Rhein Peter LDirector32.3k0.063%2 sells $264k
Donohue Michael T.Interim CFO, SVP32.2k0.062%
Connor Frank TDirector23.6k0.046%
Dulik ElenaChief Accounting Officer, SVP23.1k0.045%3 sells $269k
Dakkuri Raja AChief Financial Officer, EVP22.5k0.044%
Brown BrandonExecutive Vice President17.7k0.034%
Aggarwal ReenaDirector16.6k0.032%
Simon Richard PDirector16.4k0.032%5 sells $1.8M
Smith DashaDirector9.5k0.018%
Dolly LisaDirector2.0k<0.01%
Thissen Karen WilsonDirector1.7k<0.01%

Full register at boothcheck.com/insiders/CNS. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

CNS institutional holders · CNS research report